Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Discovery could lead to improved stem cell therapy
Whilst the human endometrium is known to harbour stem cells, this is the first time they have been obtained from the equine uterus.
Stem cells harvested from equine uterus for the first time

A new discovery could reduce pain and stress in horses undergoing stem cell therapy, according to a team of scientists who managed to harvest stem cells from the equine uterus for the first time.

Stem cells are used therapeutically in horses with tendon and joint injuries, but they are usually obtained surgically from bone marrow or fat tissue. However, stem cells can be taken from the uterus, without the need for surgical intervention, using small instruments inserted via the cervix.

Scientists from Vetmeduni Vienna collected uterine tissue samples from six mares. Suspected stem cells were separated from the endometrial epithelial cells and expanded in cell culture. Various molecular biology techniques were then used to identify potential stem cells.

The cells clearly expressed the same markers as bone marrow stem cells, according to the research team. They were also able to show that the endometrial stem cells differentiated into fat, bone, cartilage and muscle cell lines.

Whilst the human endometrium is known to harbour stem cells, this is the first time they have been obtained from the equine uterus.

“The endometrium provides a source of mesenchymal stem cells that can be easily accessed with little stress to the animals,” said senior researcher Christine Aurich.

“The cell culture results show that these cells can be of benefit not only in the treatment of uterine conditions, but that they can also replace the need for surgically obtained stem cells for therapeutic purposes in other tissue types.”

The full results have been published in the journal Stem Cell Research and Therapy.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
NSA webinar explores sheep tailing and castration

The National Sheep Association (NSA) is to host a free webinar on the castration and tail docking of lambs.

The webinar, 'Understanding the tailing and castration consultation: A guide for sheep farmers', will be hosted online on Monday, 2 March 2026 at 7.30pm.

It comes during a government consultation into the methods used for these procedures. Farmers are encouraged to engage before the consultation period closes on Monday, 9 March 2026.

The webinar offers clear and actionable guidance to support farmers to contribute meaningfully to the consultation and prepare for potential changes.

On the panel will be former SVS president Kate Hovers, farmer and vet Ann Van Eetvelt and SRUC professor in Animal Health and Veterinary Sciences Cathy Dwyer. Each panel member will utilise their own specialism and expertise to evaluate risks and outcomes to sheep farming.

Find out more about the webinar on the NSA website.